Author/Authors :
Michael G Orchard، نويسنده , , Judi C Neuss، نويسنده , , Carl M.S Galley، نويسنده , , Andrew Carr، نويسنده , , David W Porter، نويسنده , , Phillip Smith، نويسنده , , David I.C. Scopes، نويسنده , , David Haydon، نويسنده , , Katherine Vousden، نويسنده , , Colin R. Stubberfield، نويسنده , , Kate Young، نويسنده , , Martin Page، نويسنده ,
Abstract :
The first inhibitors of fungal protein: mannosyl transferase 1 (PMT1) are described. They are based upon rhodanine-3-acetic acid and several compounds have been identified, for example, 5-[[3-(1-phenylethoxy)-4-(2-phenylethoxy)phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic acid (5a), which inhibit Candida albicans PMT1 with IC50s in the range 0.2–0.5 μM. Members of the series are effective in inducing changes in morphology of C. albicans in vitro that have previously been associated with loss of the transferase activity. These compounds could serve as useful tools for studying the effects of protein O-mannosylation and its relevance in the search for novel antifungal agents.
Keywords :
Mannosyl transferase , Candida albicans , antifungal , Rhodanine.
